These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 29935195

  • 1. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
    Zhao Z, Lu J, Qu H, Wang Z, Liu Q, Yang X, Liu S, Ge J, Xu Y, Li N, Yuan Y.
    Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
    [Abstract] [Full Text] [Related]

  • 2. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
    Yuan Y, Yang X, Li Y, Liu Q, Wu F, Qu H, Gao H, Ge J, Xu Y, Wang H, Wang Y, Zhao Z.
    Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
    Zhao Z, Lu J, Han L, Wang X, Man Q, Liu S.
    Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
    [Abstract] [Full Text] [Related]

  • 4. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR, Sha JJ, Liu DM, Chen YH, Yang GL, Zhang J, Chen YY, Bo JJ, Huang YR.
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B, Wang W, Zhang X, Sun M, Wang X, Chen Z, Liu W, Wang Q, Yu N, Li X.
    BMC Cancer; 2019 Jun 03; 19(1):534. PubMed ID: 31159774
    [Abstract] [Full Text] [Related]

  • 6. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F, Aytac Vuruskan B, Vuruskan H.
    APMIS; 2016 Apr 03; 124(4):257-62. PubMed ID: 26750935
    [Abstract] [Full Text] [Related]

  • 7. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
    Gremel G, Djureinovic D, Niinivirta M, Laird A, Ljungqvist O, Johannesson H, Bergman J, Edqvist PH, Navani S, Khan N, Patil T, Sivertsson Å, Uhlén M, Harrison DJ, Ullenhag GJ, Stewart GD, Pontén F.
    BMC Cancer; 2017 Jan 04; 17(1):9. PubMed ID: 28052770
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R, Khella HW, Scorilas A, Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans A, Yousef GM.
    Cancer Med; 2016 Apr 04; 5(4):656-64. PubMed ID: 26860079
    [Abstract] [Full Text] [Related]

  • 9. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
    Saeednejad Zanjani L, Madjd Z, Abolhasani M, Andersson Y, Rasti A, Shariftabrizi A, Asgari M.
    Exp Mol Pathol; 2017 Oct 04; 103(2):218-228. PubMed ID: 29050853
    [Abstract] [Full Text] [Related]

  • 10. Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.
    Chen D, Chen W, Xu Y, Zhu M, Xiao Y, Shen Y, Zhu S, Cao C, Xu X.
    J Med Genet; 2019 Jan 04; 56(1):43-49. PubMed ID: 29967134
    [Abstract] [Full Text] [Related]

  • 11. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z, Liu Y, Yang Y, Wang J, Zhang G, Liu Z, Fu H, Wang Z, Liu H, Xu J.
    Oncotarget; 2017 Jan 31; 8(5):7548-7558. PubMed ID: 27911274
    [Abstract] [Full Text] [Related]

  • 12. Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior.
    Sugimoto M, Kohashi K, Kuroiwa K, Abe T, Yamada Y, Shiota M, Imada K, Naito S, Oda Y.
    Virchows Arch; 2016 Mar 31; 468(3):357-67. PubMed ID: 26649732
    [Abstract] [Full Text] [Related]

  • 13. Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
    Lkhagvadorj S, Kim JH, Oh SS, Lee MR, Jung JH, Chung HC, Cha SK, Eom M.
    J Korean Med Sci; 2016 Jun 31; 31(6):879-85. PubMed ID: 27247496
    [Abstract] [Full Text] [Related]

  • 14. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J, Xu Y, Zhu L, Zou Y, Kong W, Dong B, Huang J, Chen Y, Xue W, Huang Y, Zhang J.
    PLoS One; 2016 Jun 31; 11(11):e0166231. PubMed ID: 27861513
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L, Xiao L, Heng B, Mo S, Chen W, Su Z.
    Int Urol Nephrol; 2017 Jul 31; 49(7):1165-1176. PubMed ID: 28349447
    [Abstract] [Full Text] [Related]

  • 16. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM, Lu M, Yang P, Wu S, Cai C, Zhong WD, Olumi A, Young RH, Wu CL.
    Hum Pathol; 2015 Jun 31; 46(6):820-6. PubMed ID: 25827535
    [Abstract] [Full Text] [Related]

  • 17. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
    Cui ZW, Xia Y, Ye YW, Jiang ZM, Wang YD, Wu JT, Sun L, Zhao J, Fa PP, Sun XJ, Gui YT, Cai ZM.
    Asian Pac J Cancer Prev; 2012 Jun 31; 13(7):3403-8. PubMed ID: 22994768
    [Abstract] [Full Text] [Related]

  • 18. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 19. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X, Li H, Ma X, Li X, Gao Y, Ni D, Shen D, Gu L, Wang B, Zhang Y, Zhang X.
    Cell Biochem Biophys; 2015 Jan 16; 71(1):279-90. PubMed ID: 25120023
    [Abstract] [Full Text] [Related]

  • 20. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
    Zhao Z, Zhang M, Duan X, Deng T, Qiu H, Zeng G.
    J Cell Physiol; 2018 Oct 16; 233(10):6825-6838. PubMed ID: 29693713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.